Tag Archives: Elinzanetant
08
Dec
Comparing Elinzanetant with Current Options for VMS and Sleep Management
This episode notes that elinzanetant offers a targeted, non-hormonal option...
21
Nov
Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Menopause
This educational roundtable convenes leaders in women’s health to discuss t...
21
Nov
Efficacy and Safety of Elinzanetant in Vasomotor Symptoms in Women with Breast Cancer Receiving Endocrine Therapy
This educational roundtable convenes leaders in women’s health to discuss t...
24
Oct
FDA approves elinzanetant (Lynkuet) for vasomotor menopausal symptoms
The FDA has approved elinzanetant 60 mg capsules (Lynkuet; Bayer) for the t...
28
Sep
JoAnn Pinkerton, MD, highlights long-term safety and efficacy of elinzanetant
The recently published 52-week OASIS-3 trial evaluated the safety and efficacy of elinzanetant,...
11
Aug
Weight and Muscle Mass Outcomes With Elinzanetant
Video content above is prompted by the following: The OASIS-3 subanalysis revealed favorable bo...
11
Aug
BMD Biomarker Outcomes With Elinzanetant vs Placebo: Clinical Relevance and Implications
Video content above is prompted by the following: The OASIS-3 bone mineral density (BMD) subana...
